Final answer:
The DEA requires that Schedule II controlled substances be kept in a separate inventory record to prevent misuse and diversion, while still ensuring legitimate medical use. This regulation is part of the strict controls for drugs with high potential for abuse.
Step-by-step explanation:
According to the Drug Enforcement Administration (DEA) regulations, it is indeed true that Schedule II controlled substances must be meticulously tracked. The Controlled Substances Act (CSA) stipulates strict record-keeping and security measures for substances that have a high potential for abuse but can be used medically. Schedule II drugs are considered to have a high potential for abuse, which may lead to severe psychological or physical dependence.
Pharmacies, hospitals, and other registrants handling these substances must keep accurate records of each transaction involving a Schedule II drug. This includes maintaining a separate inventory record, distinct from other substances. These inventory records must be kept for a minimum of two years and be readily available for inspection by DEA officials.
The purpose of this stringent regulation is to prevent diversion and misuse of Schedule II drugs while still allowing for their legitimate medical use. Therefore, the final answer is 'A. True' with the explanation that Schedule II drugs require strict inventory records as per DEA regulation.